Company: SMNR
Filing Date: 2025-08-13
Form Type: 424B3
Source: 0001193125-25-179226
Chunk: 107

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-13
Form: 424B3
Chunk 107
---
,000,000 |     | Outstanding  
 Amount as of 
 March 31,    
 2025         | 1,408,200 |
|:-----|:----|:--------------------------------------------------|:----|:----------|----------:|:----|:-------------|----------:|
| 2023 |     | FutureTech Convertible Promissory Note (2)        |     | $         |   825,000 |     | $            |   825,000 |
| 2023 |     | Second FutureTech Convertible Promissory Note (3) |     | $         |   450,000 |     | $            |   450,000 |
| 2024 |     | Sponsor Extension Convertible Promissory Note (4) |     | $         |   180,000 |     | $            |   115,037 |
| 2024 |     | Scilex Convertible Promissory Note (5)            |     | $         |   180,000 |     | $            |   120,482 |

| (1) | On April 11, 2023, Denali issued the Sponsor Convertible Promissory Note for working capital purposes in the                                                                                                                                            
 total principal amount of up to $825,000 to the Sponsor (the “Initial Principal Amount”). The Sponsor Convertible Promissory Note was issued with an initial principal balance of $412,500, with the remaining $412,500 drawable at                     
 Denali’s request prior to the maturity of the Sponsor Convertible Promissory Note. On December 29, 2023, Denali and the Sponsor agreed that, in addition to the Initial Principal Amount, Denali may request an additional aggregate amount of up       
 to $157,500, which may be drawn down in one or more tranches at any time prior to the maturity date of the Sponsor Convertible Promissory Note, raising the total limit up to $1,000,000. On April 2, 2024, Denali and Sponsor agreed that, in addition 
 to the Initial Principal Amount, Denali may request an additional aggregate amount of up to $186,800, which may be drawn down in one or more tranches at any time prior to the maturity date, raising the total limit up to $1,200,000. On January 27,  
 2025, Denali and Sponsor agreed that, in addition to the Initial Principal Amount,